Loading clinical trials...

COMPLETED

Evolution of Body Connection After Surgery

Evolution of Body Connection and Identity Post-surgery: The Pancreas Cancer Case

NCT04422730•Institut Paoli-Calmettes

Summary

Evaluation of psychological impact of patients after pancreatectomy because of cancer diagnosis. Patients will be evaluated with questionnaires after and before intervention. 3 control groups will be used to compare de psychological impact.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patient is older than 18 years old
•With a good understanding and practice of the French language
•And depending on the group, experimental or control, presenting:
•* pancreatic cancer expected to be treated with pancreatectomy or planned to be treated with pancreatectomy excluding cancer or breast cancer scheduled to be treated with mastectomy or acute leukaemia at a recent diagnosis (21 days).
•No patient's opposition to the information provided
•Affiliated to the social security plan or beneficiary

Exclusion Criteria

•Other medical or psychiatric condition,
•Level of cognitive efficiency incompatible with response to questions about himself,
•A person in an emergency situation, a person under legal protection or unable to express the non opposition to their participation to research.

Locations (1)

Institut Paoli-Calmettes

Marseille, France

Key Dates

Start Date

June 30, 2020

Primary Completion Date

March 5, 2023

Completion Date

March 5, 2024

Last Updated

June 18, 2025

Enrollment

129

ACTUAL participants

Conditions

Pancreas Cancer

Interventions

Psychological evaluation

BEHAVIORAL

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

NCT04485286

Lung CancerRadiation Fibrosis+2 more

View study

RECRUITINGPHASE1/PHASE2

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

NCT04605913

Pancreas CancerMetastatic Pancreatic Cancer+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evolution of Body Connection After Surgery

Inclusion Criteria

Exclusion Criteria

Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

A Study of MGC026 in Participants With Advanced Solid Tumors

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors